"What" Series

What is Pharmacokinetics?

1 April 2024
2 min read

Pharmacokinetics (PK) is the study of how a drug moves through the body, which includes the processes of absorption, distribution, metabolism, and excretion. This scientific discipline is essential for understanding how a drug is absorbed, how it is transformed, and how it is eliminated from the body.

Key aspects of pharmacokinetics include:

·Absorption: The process by which a drug enters the bloodstream from the site of administration, such as the gastrointestinal tract, skin, or injection site.

·Distribution: The movement of the drug throughout the body, including crossing membranes and reaching target tissues or organs. The distribution can affect the concentration of the drug at the site of action.

·Metabolism: The chemical transformation of the drug within the body, primarily in the liver, which can make the drug more or less active or easier to excrete. Metabolism often involves converting the drug into metabolites, which are compounds that are often more water-soluble and can be more easily eliminated from the body.

·Excretion: The elimination of the drug and its metabolites from the body, typically through urine, feces, or exhalation.

·Pharmacokinetic Profiling: The creation of a drug's concentration-time curve, which provides a visual representation of how the drug's concentration in the blood changes over time.

·Half-Life: The time it takes for the concentration of a drug in the body to decrease by half. This is a critical parameter for determining the dosing frequency of a drug.

·Bioavailability: The extent to which the drug becomes available at the site of action, which can be influenced by the drug's formulation and route of administration.

·Pharmacokinetic Modeling: The use of mathematical models to describe and predict the pharmacokinetic behavior of a drug, which can aid in drug development and dosing regimen optimization.

Pharmacokinetics is vital for the safe and effective use of drugs, as it helps in determining the appropriate dosing, understanding drug-drug interactions, and predicting the drug's therapeutic and toxic effects. It is a fundamental component of clinical pharmacology and drug development.

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Japan sanctions VYLOY™ (zolbetuximab) by Astellas as a new therapeutic for stomach cancer management
Latest Hotspot
3 min read
Japan sanctions VYLOY™ (zolbetuximab) by Astellas as a new therapeutic for stomach cancer management
1 April 2024
Astellas Pharma Inc. announced that Japan's Ministry of Health, Labour and Welfare approved VYLOY™ (zolbetuximab), an anti-CLDN18.2 drug, for advanced and inoperable metastatic stomach cancer patients positive for CLDN18.2.
Read →
Global New Drug Research and Development Progress Weekly Report(3.25-3.31)
Drug Highlight
18 min read
Global New Drug Research and Development Progress Weekly Report(3.25-3.31)
1 April 2024
Curated Selection of the Latest Developments in the Field of New Drug Research and Development: A Quick Overview of Progress in New Drug R&D, Pharmaceutical Deals, and Cutting-Edge Technologies from This Week.
Read →
FDA Approves First and Only Once-Daily Single-Pill Combination Therapy for Pulmonary Arterial Hypertension
Hot Spotlight
10 min read
FDA Approves First and Only Once-Daily Single-Pill Combination Therapy for Pulmonary Arterial Hypertension
29 March 2024
On March 22, Johnson & Johnson announced FDA approval of OPSYNVI®, their new drug for treating WHO Group 1 PAH and class II-III PAH in adults. OPSYNVI® combines macitentan and tadalafil in a single tablet.
Read →
Phase II Trial Begins for ABY-025 PET Diagnostic in Gastric and Esophageal Cancers
Latest Hotspot
3 min read
Phase II Trial Begins for ABY-025 PET Diagnostic in Gastric and Esophageal Cancers
29 March 2024
Initial enrollment of patients with stomach and esophageal cancer has begun for a second-stage mixed studies trial, utilizing Affibody's ABY-025 diagnostic tool for positron emission tomography.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.